Bausch Health Companies Inc.
NYSEBausch Health Companies enters its Q2 print today with the stock up 3.5% on the session to $4.68 — still trading at a steep discount to the Street's mean target of $7.30, a gap that has persisted all month and frames the central question heading into the release. The positioning setup remains notably relaxed despite a month of steady short accumulation. Short interest has climbed…
Snapshot as of 6 Aug 2026
Bausch Health Companies enters its Q2 print today with the stock up 3.5% on the session to $4.68 — still trading at a steep discount to the Street's mean target of $7.30, a gap that has persisted all month and frames…
Bausch Health Companies reports tomorrow with a quietly interesting setup: short interest has climbed 22% over the past month, the ORTEX short score has drifted higher all week, and the stock trades at $4.52 — roughly…
Bausch Health Companies Inc. heads into its May 7 Q1 results with the most bullish options read in nearly a year — a sharp contrast to the heavy put positioning that defined most of 2026. The standout this week is the…
BHC heads into its April 29 Q1 results with options markets flashing an unusually bullish lean — a notable contrast to the cautious positioning more typical ahead of a heavily indebted pharma print. The options signal…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BHC — free to start on ORTEX.
Sign up for free →Open BHC on ORTEX